News
H.C. Wainwright has taken the unusual step of setting a $0 price target for troubled biotech Sarepta Therapeutics ...
MyChesCo on MSN46m
FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver FailureThe U.S. Food and Drug Administration on Friday placed Sarepta Therapeutics’ gene therapy trials for limb girdle muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback